Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1a, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation SCLC cells were treated with cDDP (10 μg/ml) for 24 hr (SCLC_cDDP) or untreated (SCLC(-)). Selected regions include: ASS1_E-box, E-box at the ASS1 promoter; ASS1_Exon1, Exon 1 of ASS1 locus including the transcription start site; MYC_Ebox; E-box located at the c-Myc promoter; MYC_P1, romoter 1 at the ASS1 promoter; MYC_P2; Promoter 2 at the ASS1 promoter; SssI, CpG methylase-treated DNA (as a positive control); WGA, whole genome amplified DNA (as a basal line control).
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